Nexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBS System) is indicated for noninvasive mapping of the primary motor cortex of the brain to its cortical gyrus. The NBS System provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning. The NBS System is not intended to be used during a surgical procedure. The NBS System is intended to be used by trained clinical professionals.
Publicado el 14 de junio de 2017 · Inicio del retiro: 14 de marzo de 2017
Resumen
FDA registra el retiro Z-2319-2017 de dispositivos médicos de Clase II, publicado el 14 de junio de 2017 e iniciado el 14 de marzo de 2017. Empresa responsable: Nexstim PLC; Estado: En curso; Cantidad reportada: 11 units.; Lote: Serial numbers: NBS101, NBS106, NBS140, NBS141, NBS145, NBS148, NBS155, NBS159, NBS163, NBS164, NBS166. NBS158 has been scrapped. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Software defect: the NBS software may accidentally generate duplicate copies of one or several files.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Nexstim PLC
- Distribuidor
- Worldwide Distribution - US to GA only, Foreign: Europe
- Lote
- Serial numbers: NBS101, NBS106, NBS140, NBS141, NBS145, NBS148, NBS155, NBS159, NBS163, NBS164, NBS166. NBS158 has been scrapped.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- Finland
Retiros relacionados
- FDALevophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest,21 de junio de 2017
- FDANBS System 4 (sw version 4.0 or higher), Software update to 4.3.3 and NBS System 5 (sw version 5.0 or higher),14 de junio de 2017
- FDADePuy Synthes various orthopedic instruments modified by U.S. Distributors These instruments are used in14 de junio de 2017
- FDAMedTest DX Assayed Human Multi Sera Control Level 1 (HNC200) and Level 2 (HEC200) HEC200 " Sml amber glass14 de junio de 2017
- FDAResponse BandLoc 5.5/6.0 Tensioner Instrument The Tensioner Instrument (01-1102-1000) is utilized to allow the14 de junio de 2017
- FDALapSac Introducer, Supplied sterilized by ethylene oxide gas in peel-open packages. Used to aid in the14 de junio de 2017
Preguntas sobre este retiro
¿Nexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBS System) is indicated for noninvasive mapping of the primary motor cortex of the brain to its cortical gyrus. The NBS System provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning. The NBS System is not intended to be used during a surgical procedure. The NBS System is intended to be used by trained clinical professionals. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2319-2017 el 14 de junio de 2017. Peligro reportado: Software defect: the NBS software may accidentally generate duplicate copies of one or several files.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter